Search Results - "D'Urzo, Anthony D"

Refine Results
  1. 1
  2. 2

    Weighing the evidence for pharmacological treatment interventions in mild COPD; a narrative perspective by Singh, Dave, D'Urzo, Anthony D, Donohue, James F, Kerwin, Edward M

    Published in Respiratory research (08-07-2019)
    “…There is increasing focus on understanding the nature of chronic obstructive pulmonary disease (COPD) during the earlier stages. Mild COPD (Global Initiative…”
    Get full text
    Journal Article
  3. 3

    Variation Among Spirometry Interpretation Algorithms by D'Urzo, Katrina A, Mok, Florence, D'Urzo, Anthony D

    Published in Respiratory care (01-10-2020)
    “…Several algorithms exist to facilitate spirometric interpretation in clinical practice, yet there is a lack of consensus on how spirometric criteria for…”
    Get full text
    Journal Article
  4. 4

    Importance of distinguishing between asthma and chronic obstructive pulmonary disease in primary care by D'Urzo, Anthony D, Price, David, Kardos, Peter, Maleki-Yazdi, M Reza

    Published in Canadian family physician (01-09-2021)
    “…To facilitate distinction between asthma and chronic obstructive pulmonary disease (COPD) in day-to-day primary care practice, and provide practical treatment…”
    Get full text
    Journal Article
  5. 5

    Airway hyperresponsiveness in patients with normal spirometry results and symptoms compatible with asthma: Primary care retrospective chart review by Chen, Amy, D'Urzo, Katrina A, D'Urzo, Anthony D

    Published in Canadian family physician (01-03-2021)
    “…To evaluate the proportion of patients with symptoms suggestive of asthma and normal lung function who exhibit airway hyperreactivity with methacholine…”
    Get full text
    Journal Article
  6. 6

    Aclidinium bromide/formoterol fumarate as a treatment for COPD: an update by D'Urzo, Anthony D, Singh, Dave, Donohue, James F, Chapman, Kenneth R, Wise, Robert A

    Published in Expert review of respiratory medicine (02-09-2021)
    “…: Aclidinium/formoterol is a long-acting muscarinic antagonist (LAMA) and long-acting β -agonist (LABA) dual bronchodilator used as a maintenance treatment for…”
    Get more information
    Journal Article
  7. 7

    Practical considerations when prescribing a long-acting muscarinic antagonist for patients with COPD by D'Urzo, Anthony D, Kardos, Peter, Wiseman, Russell

    “…COPD is characterized by persistent airflow limitation, progressive breathlessness, cough, and sputum production. Long-acting muscarinic antagonists (LAMAs)…”
    Get full text
    Journal Article
  8. 8
  9. 9

    New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology by D'Urzo, Anthony D, Cazzola, Mario, Hanania, Nicola A, Buhl, Roland, Maleki-Yazdi, M Reza

    “…COPD causes considerable health and economic burden worldwide, with incidence of the disease expected to continue to rise. Inhaled bronchodilators, such as…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Diagnosis of asthma by D'Urzo, Anthony D

    “…It could be argued that airflow obstruction defined by a reduction in the ratio of FEV1 and forced vital capacity (FVC) is irreversible in COPD since, by…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study by D'Urzo, Anthony D, Rennard, Stephen I, Kerwin, Edward M, Mergel, Victor, Leselbaum, Anne R, Caracta, Cynthia F

    Published in Respiratory research (14-10-2014)
    “…Combining two long-acting bronchodilators with complementary mechanisms of action may provide treatment benefits to patients with chronic obstructive pulmonary…”
    Get full text
    Journal Article
  20. 20